Pacific Biosciences of California Inc
F:P09
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pacific Biosciences of California Inc
F:P09
|
US |
|
G
|
Gemfields Group Ltd
JSE:GML
|
GG |
|
S
|
Silgan Holdings Inc
F:SL3
|
US |
|
S
|
SoftBank Group Corp
OTC:SFTBF
|
JP |
|
C
|
Cherat Cement Company Ltd
KAR:CHCC
|
PK |
Wall St Price Targets
P09 Price Targets Summary
Pacific Biosciences of California Inc
According to Wall Street analysts, the average 1-year price target for
P09 is 2.42 EUR with a low forecast of 1.5 EUR and a high forecast of 3.73 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is P09's stock price target?
Price Target
2.42
EUR
According to Wall Street analysts, the average 1-year price target for
P09 is 2.42 EUR with a low forecast of 1.5 EUR and a high forecast of 3.73 EUR.
What is the Revenue forecast for Pacific Biosciences of California Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Gross Profit forecast for Pacific Biosciences of California Inc?
Projected CAGR
26%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 36%. The projected CAGR for the next 3 years is 26%.